24 Feb 2021 - Hearing solutions company Cochlear (ASX:COH) has received US Food and Drug Administration (FDA) clearance and CE Mark accreditation for the new Cochlear Baha 6 Max Sound Processor.
24 Feb 2021 - Scentre Group (AXS:SCG) report a full-year loss of $3.7 billion, from a profit of $1.18 billion a year ago.
24 Feb 2021 - Stay-at-home consumers have helped push Woolworth’s (ASX:WOW) profit’s up 15.9 per cent to $1.14 billion for the half year.
24 Feb 2021 - Following mixed leads from US markets, the ASX looks set to open lower this morning. The US Federal Reserve chair Jerome Powell says recovery is ‘far from complete.’ He also reiterated that the central bank planned to keep up low interest rates and large-scale bond buying. The tech sell-off continues with the NASDAQ continuing to be hit. And Seven West Media (ASX:SWM) has signed a Letter of Intent to provide news content to Facebook.
23 Feb 2021 - Social media giant Facebook has agreed to lift its ban on Australian news content. Rising commodity prices continued to be the stimulant for the energy and mining rally, with BHP (ASX:BHP) and Oil Search (ASX:OSH) all edging higher. Industrial property investment heavyweight Centuria Industrial REIT (ASX:CIP) has successfully snapped up a modern warehouse in the north-western Sydney suburb of Bella Vista.
dd Mmm 2021 - The ASX opened steady and zig-zagged throughout the morning. Mining and energy heavyweights have benefitted from rising commodity prices, while falls in IT, telcos and consumer discretionaries cancelled out these gains to keep the ASX200 flat at 6775 at noon.
23 Feb 2021 - Retirement and lifestyle property group Ingenia Communities (ASX:INA) has successfully acquired two new holiday projects in Queensland.
23 Feb 2021 - Dairy and snack producer Freedom Foods Group (ASX:FNP) has today been served a second class action in the Victorian Supreme Court.
23 Feb 2021 - Australian-based ship builder Austal (ASX:ASB) has farewelled US chief Craig Perciavalle.
23 Feb 2021 - Pharmaceutical developer Starpharma (ASX:SPL) has received EU approval for the company’s antiviral nasal spray Viraleze.
